Express Scripts drops Ingrezza!

Discussion in 'Neurocrine' started by anonymous, May 2, 2019 at 6:58 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Come July 1st Austedo is preferred and Ingrezza is being dropped from Express Scripts! Can I jump off this sinking ship anytime soon?!
     

  2. anonymous

    anonymous Guest

    Less than 1% of revenue comes from
    Express scripts, but please, jump off the ship. You’re probably weighing us down
     
  3. anonymous

    anonymous Guest

    Not the poster but ESI is effects more than 1% of our business. Shares fell 5% on that announcement alone. I don't know what the answer is but I know my shares aren't worth what I was told they would be worth.
     
  4. anonymous

    anonymous Guest

    Did you see Q1 financials?
     
  5. anonymous

    anonymous Guest

    Q1 financials blah blah blah. Stock was worth $122 in September. $79 now but yeah, we're awesome.
     
  6. anonymous

    anonymous Guest

    This company sucks and the reps are the worst! Underhanded and dirty! Gets you nowhere fast!
     
  7. anonymous

    anonymous Guest

    Yea, we're back

    Express Scripts Okays Coverage for TD Medication the announcement that Express Scripts – the largest pharmacy benefit manager in the country – has added the medication valbenazine to its official list of covered drugs as of July 1 2021
     
  8. anonymous

    anonymous Guest

    Is new volume offsetting the discount that cost?
     
  9. anonymous

    anonymous Guest

    awww looks like someone didn’t get an offer letter :’(
     
  10. anonymous

    anonymous Guest

    Dude you are such a joke. You get paid to defend Neurocrine’s honor? Go call in some prior authorizations. Whatever it takes to win.